𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparison of statistical methods for prenatal screening for Down syndrome

✍ Scribed by Christopher J. Williams; Sauchi Stephen Lee; Rachel A. Fisher; Lois H. Dickerman


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
151 KB
Volume
15
Category
Article
ISSN
1524-1904

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Economic evaluation of prenatal screenin
✍ Tryfon Beazoglou; Dennis Heffley; John Kyriopoulos; Anthony Vintzileos; Peter Be πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

Maternal serum screening for Down syndrome involves biochemical tests such as alpha-fetoprotein ( FP), human chorionic gonadotrophin (hCG) and unconjugated oestriol (uE 3 ), either alone or in combination, that have variable detection and false-positive rates. Choosing a screening protocol requires

Screening for Down syndrome at 14 weeks
✍ N. J. Wald; H. C. Watt; J. E. Haddow; G. J. Knight πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 1 views

To investigate whether statistical parameters used in Down syndrome screening between 15 and 22 weeks of pregnancy can be used at 14 weeks, we assayed alpha-fetoprotein (AFP), unconjugated oestriol (uE 3 ), total human chorionic gonadotrophin (hCG), free -hCG, free -hCG, and inhibin-A in 16 pregnanc

Economic evaluation of prenatal carrier
✍ Anthony M. Vintzileos; Cande V. Ananth; Allan J. Fisher; John C. Smulian; Debra πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Objective: The objective of this study was to conduct an economic evaluation of routine prenatal carrier testing for fragile X syndrome. Methods: This economic analysis was conducted from the societal perspective. A cost-benefit equation was developed based on the premise that the cost of routi